1. Pharmerit International, Rotterdam, The Netherlands;
2. Astellas Pharma International, Leiden, The Netherlands;
3. Institute for Medical Technology Assessment and Department of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands